NomosLogic
Back to Blog
DrugDiscoveryAIinBiologyomputationalBiologyFalsifiableAIBiotechPrecisionMedicine

AI drug discovery is becoming more powerful. The cost of being wrong is rising with it.

Matt HardyOctober 15, 20261 min read

AI drug discovery is becoming more powerful. The cost of being wrong is rising with it.

Permanent modalities demand more than plausible predictions. They demand mechanisms that can be inspected, kill-conditions defined before the result exists, calibrated predictions that know when to abstain, and provenance that survives scrutiny.

This is the architecture behind falsifiable AI drug discovery at NomosLogic | Heuresis: probabilistic systems generate hypotheses; deterministic gates decide what counts as evidence.

Because in therapeutics, a model can be right—and still be inadmissible.

NomosLogic. Deterministic. Exact. Yours.

#DrugDiscovery #AIinBiology #ComputationalBiology #FalsifiableAI #Biotech #PrecisionMedicine

DrugDiscovery,AIinBiology,omputationalBiology,FalsifiableAI,Biotech,PrecisionMedicine

MH

Matt Hardy

Published on October 15, 2026

Permanent modalities demand more than plausible predictions. They demand mechanisms that can be inspected, kill-conditions defined before the result exists, calibrated predictions that know when to abstain, and provenance that survives scrutiny.